Lee Pelton Revealed Alzheimer’s Disease Diagnosis
The former Boston Foundation leader is sharing his story to increase awareness of the condition.
Updated on Oct. 14, 2026 in Alzheimer’s
Lee Pelton, former president and CEO of The Boston Foundation, announced his Alzheimer's disease diagnosis in a recent personal essay. Pelton disclosed the news after experiencing a decline in his short-term memory.
Why it matters
By sharing his experience, Pelton seeks to shed light on Alzheimer's disease and honor the memory of his mother, who died from the condition. His public disclosure highlights the importance of awareness and understanding regarding cognitive decline.
Pelton's disclosure follows a period of increasing short-term memory decline that became more intense over recent weeks. His experience is consistent with the early symptoms often reported in Alzheimer's disease, though his medical data remains private.
The players
Lee Pelton
A former president of Emerson College and former CEO of The Boston Foundation who currently serves on the GBH Board of Trustees.
The Boston Foundation
A major philanthropic organization in Boston focused on community health and social impact where Pelton served as president and CEO.
The NonProfit Times
A leading trade publication that tracks influential nonprofit leaders and industry trends.
The details
Alzheimer's disease is a neurodegenerative condition often characterized by the buildup of proteins in the brain, which leads to memory loss and cognitive impairment. Initial signs frequently manifest as difficulty with short-term recall, which can intensify as the underlying brain changes progress. Publicly acknowledging these symptoms can be a vital step for individuals and families navigating the diagnostic process.
Timeline
In 2024, Pelton was named a powerful nonprofit leader and received the Harvard Medal.
Pelton stepped down as CEO of The Boston Foundation in September 2026.
Pelton discussed his essay on Boston Public Radio on October 14, 2026.
Health Landscape
The public discourse around Alzheimer's disease has shifted as more leaders share their personal experiences to reduce stigma. This trend supports broader efforts to normalize conversations about cognitive health in the workplace and community.
Pelton's experience underscores the importance of monitoring changes in short-term memory, as these can be early indicators of cognitive health concerns. If you notice persistent lapses, it is worth discussing these changes with your doctor to explore potential causes and next steps.
The takeaway
Recognizing early cognitive symptoms is a key step toward understanding your brain health. Always consult with a qualified physician to discuss any concerns regarding memory or cognitive performance.
Further reading
For more information on the latest research and support resources, visit Alzheimer’s.
Source note: This article includes information reported by GBH.
